Girish Dhall, MD
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Combination of Avutometinib and Defactinib for Treatment of Relapsed, Refractory, Metastatic, or Unresectable Malignant Peripheral Nerve Sheath Tumor (NCT07743554) | Girish Dhall, MD | 2027-01-01 |
| Study of Cabozantinib With Selumetinib for Plexiform Neurofibromas (NCT06502171) | Girish Dhall, MD | 2026-08-01 |
Track Girish Dhall, MD automatically
Every clearance here is in the API, with alerts when new ones post.